Smell Dysfunction
10
5
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Post-Covid-19 Patients Follow-up Study
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
The Effectiveness of Steroid Nasal Drops in the Olfactory Cleft Combined With Olfactory Training for Patients With PIOD
The Efficacy of Olfactory Cleft Steroid Drops in Patients With CRS With Olfactory Cleft Obstruction
Effects of Isotretinoin on Smell
Prospective Registery of Smell/Taste Clinic Ear/Nose/Throat
Olfactory Biopsies
Olfactory Training on Smell Dysfunction Patients in HK
The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions
Omega-3 Supplementation for Smell Dysfunction